Oxysterols: Old Tale, New Twists

Annual Review of Pharmacology and Toxicology

Volumn 56, Issue , 2016, Pages 447-467

  Luu, Winnie ^a   Sharpe, Laura J ^a   Capell Hattam, Isabelle ^a   Gelissen, Ingrid C ^b   Brown, Andrew J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Hedgehog pathway; Immune system; Oxysterol

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; EPSTEIN BARR VIRUS INDUCED G PROTEIN COUPLED RECEPTOR 2; ESTROGEN RECEPTOR; LIPOPROTEIN; LIVER X RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OXYSTEROL; PROTEIN; RETINOIC ACID RECEPTOR; SONIC HEDGEHOG PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN; UNCLASSIFIED DRUG; CHOLESTEROL; STEROL;

ADAPTIVE IMMUNITY; ANALYTIC METHOD; ANTIVIRAL ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BIOLOGICAL ACTIVITY; CELL FUNCTION; CELL TRANSPORT; CHOLESTEROL METABOLISM; DEGENERATIVE DISEASE; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; LIGAND BINDING; LIPID METABOLISM; MOLECULAR BIOLOGY; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; HOMEOSTASIS; METABOLISM; PHYSIOLOGY;

ANIMALS; CHOLESTEROL; HEDGEHOG PROTEINS; HOMEOSTASIS; HUMANS; STEROLS;

EID: 84954141557     PISSN: 03621642     EISSN: 15454304     Source Type: Book Series    
DOI: 10.1146/annurev-pharmtox-010715-103233     Document Type: Article

References (142)

1. Kandutsch AA, Chen HW, Heiniger HJ. 1978. Biological activity of some oxygenated sterols. Science 201:498-501
2. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:915-24
3. Brown AJ, JessupW. 1999. Oxysterols and atherosclerosis. Atherosclerosis 142:1-28
4. Gill S, Chow R, Brown AJ. 2008. Sterol regulators of cholesterol homeostasis and beyond: The oxysterol hypothesis revisited and revised. Prog. Lipid Res. 47:391-404
5. Russell DW. 2003. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 72:137-74
6. Mast N, Annalora AJ, Lodowski DT, Palczewski K, Stout CD, Pikuleva IA. 2011. Structural basis for three-step sequential catalysis by the cholesterol side chain cleavage enzyme CYP11A1. J. Biol. Chem. 286:5607-13
7. Bjorkhem I, LutjohannD,Diczfalusy U, Stahle L, AhlborgG,Wahren J. 1998. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 39:1594-600
8. Hannedouche S, Zhang J, YiT, ShenW,Nguyen D, et al. 2011. Oxysterols direct immune cell migration via EBI2. Nature 475:524-27
9. Nelson JA, Steckbeck SR, Spencer TA. 1981. Biosynthesis of 24,25-epoxycholesterol from squalene 2,3;22,23-dioxide. J. Biol. Chem. 256:1067-68
10. Goyal S, Xiao Y, Porter NA, Xu L, Guengerich FP. 2014. Oxidation of 7-dehydrocholesterol and desmosterol by human cytochrome P450 46A1. J. Lipid Res. 55:1933-43
11. Honda A,MiyazakiT, Ikegami T, Iwamoto J,Maeda T, et al. 2011. Cholesterol 25-hydroxylation activity of CYP3A. J. Lipid Res. 52:1509-16
12. Brown AJ, JessupW. 2009. Oxysterols: sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis. Mol. Asp. Med. 30:111-22
13. Terao J. 2014. Cholesterol hydroperoxides and their degradation mechanism. Subcell. Biochem. 77:83-91
14. Brown AJ, Leong SL, Dean RT, JessupW. 1997. 7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque. J. Lipid Res. 38:1730-45
15. Shinkyo R, Xu L, Tallman KA, Cheng Q, Porter NA, Guengerich FP. 2011. Conversion of 7-dehydrocholesterol to 7-ketocholesterol is catalyzed by human cytochrome P450 7A1 and occurs by direct oxidation without an epoxide intermediate. J. Biol. Chem. 286:33021-28
16. Bjorkhem I, Diczfalusy U, Lovgren-Sandblom A, Starck L, JonssonM, et al. 2014. On the formation of 7-ketocholesterol from 7-dehydrocholesterol in patients with CTX and SLO. J. Lipid Res. 55:1165-72
17. TempelW,Grabovec I, MacKenzie F, Dichenko YV, Usanov SA, et al. 2014. Structural characterization of human cholesterol 7-hydroxylase. J. Lipid Res. 55:1925-32
18. Larsson H, Bottiger Y, Iuliano L, Diczfalusy U. 2007. In vivo interconversion of 7-hydroxycholesterol and 7-ketocholesterol, potential surrogate markers for oxidative stress. Free Radic. Biol. Med. 43:695-701
19. Mitic T, Shave S, Semjonous N, McNae I, Cobice DF, et al. 2013. 11-Hydroxysteroid dehydrogenase type 1 contributes to the balance between 7-keto-and 7-hydroxy-oxysterols in vivo. Biochem. Pharmacol. 86:146-53
20. Diczfalusy U. 2013. On the formation and possible biological role of 25-hydroxycholesterol. Biochimie 95:455-60
21. Dzeletovic S, Babiker A, Lund E, Diczfalusy U. 1995. Time course of oxysterol formation during in vitro oxidation of low density lipoprotein. Chem. Phys. Lipids 78:119-28
22. Sanchez-Guijo A, Oji V, Hartmann MF, Schuppe HC, Traupe H, Wudy SA. 2015. High levels of oxysterol sulfates in serum of patients with steroid sulfatase deficiency. J. Lipid Res. 56:403-12
23. Ren S, Ning Y. 2014. Sulfation of 25-hydroxycholesterol regulates lipid metabolism, inflammatory responses, and cell proliferation. Am. J. Physiol. Endocrinol. Metab. 306:E123-30
24. Meng LJ, Griffiths WJ, Nazer H, Yang Y, Sjovall J. 1997. High levels of (24S)-24-hydroxycholesterol 3-sulfate, 24-glucuronide in the serum and urine of children with severe cholestatic liver disease. J. Lipid Res. 38:926-34
25. Lin CY, Morel DW. 1996. Esterification of oxysterols in human serum: effects on distribution and cellular uptake. J. Lipid Res. 37:168-78
26. Dzeletovic S, Breuer O, Lund E, Diczfalusy U. 1995. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 225:73-80
27. OlkkonenVM, Li S. 2013. Oxysterol-binding proteins: sterol and phosphoinositide sensors coordinating transport, signaling and metabolism. Prog. Lipid Res. 52:529-38
28. Suchanek M, Hynynen R,Wohlfahrt G, LehtoM, JohanssonM, et al. 2007. The mammalian oxysterolbinding protein-related proteins (ORPs) bind 25-hydroxycholesterol in an evolutionarily conserved pocket. Biochem. J. 405:473-80
29. Weber-Boyvat M, Kentala H, Peranen J, Olkkonen VM. 2014. Ligand-dependent localization and function of ORP-VAP complexes at membrane contact sites. Cell. Mol. Life Sci. 72:1967-87
30. Hynynen R, SuchanekM, Spandl J, Back N, Thiele C, Olkkonen VM. 2009. OSBP-related protein 2 is a sterol receptor on lipid droplets that regulates the metabolism of neutral lipids. J. Lipid Res. 50:1305-15
31. Charman M, Colbourne TR, Pietrangelo A, Kreplak L, Ridgway ND. 2014. Oxysterol-binding protein (OSBP)-related protein 4 (ORP4) is essential for cell proliferation and survival. J. Biol. Chem. 289:15705-17
32. Phillips MC. 2014. Molecular mechanisms of cellular cholesterol efflux. J. Biol. Chem. 289:24020-29
33. TerasakaN, Yu S, Yvan-Charvet L, Wang N, Mzhavia N, et al. 2008. ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet. J. Clin. Investig. 118:3701-13
34. Wang N, Yvan-Charvet L, Lutjohann D, Mulder M, Vanmierlo T, et al. 2008. ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain. FASEB J. 22:1073-82
35. Tarling EJ, Bojanic DD, Tangirala RK, Wang X, Lovgren-Sandblom A, et al. 2010. Impaired development of atherosclerosis in Abcg1/Apoe/mice: identification of specific oxysterols that both accumulate in Abcg1/Apoe/tissues and induce apoptosis. Arterioscler. Thromb. Vasc. Biol. 30:1174-80
36. Terasaka N,Wang N, Yvan-Charvet L, Tall AR. 2007. High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1. PNAS 104:15093-98
37. Peyrot SM, Nachtergaele S, Luchetti G, Mydock-McGrane LK, Fujiwara H, et al. 2014. Tracking the subcellular fate of 20(S)-hydroxycholesterol with click chemistry reveals a transport pathway to theGolgi. J. Biol. Chem. 289:11095-110
38. Radhakrishnan A, Sun LP, Kwon HJ, Brown MS, Goldstein JL. 2004. Direct binding of cholesterol to the purified membrane region of SCAP: mechanism for a sterol-sensing domain. Mol. Cell 15:259-68
39. Radhakrishnan A, Ikeda Y, Kwon HJ, Brown MS, Goldstein JL. 2007. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Oxysterols block transport by binding to Insig. PNAS 104:6511-18
40. Gale SE,Westover EJ, Dudley N, Krishnan K, Merlin S, et al. 2009. Side chain oxygenated cholesterol regulates cellular cholesterol homeostasis through direct sterol-membrane interactions. J. Biol. Chem. 284:1755-64
41. Kristiana I, Luu W, Stevenson J, Cartland S, Jessup W, et al. 2012. Cholesterol through the looking glass: Ability of its enantiomer also to elicit homeostatic responses. J. Biol. Chem. 287:33897-904
42. Olsen BN, Schlesinger PH, Baker NA. 2009. Perturbations of membrane structure by cholesterol and cholesterol derivatives are determined by sterol orientation. J. Am. Chem. Soc. 131:4854-65
43. Olsen BN, Schlesinger PH, Ory DS, Baker NA. 2011. 25-Hydroxycholesterol increases the availability of cholesterol in phospholipid membranes. Biophys. J. 100:948-56
44. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. 1996. An oxysterol signalling pathway mediated by the nuclear receptor LXR. Nature 383:728-31
45. DeBose-Boyd RA. 2008. Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res. 18:609-21
46. Gill S, Stevenson J, Kristiana I, Brown AJ. 2011. Cholesterol-dependent degradation of squalene monooxygenase, a control point in cholesterol synthesis beyond HMG-CoA reductase. Cell Metab. 13:260-73
47. Schroepfer GJ Jr. 2000. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol. Rev. 80:361-554
48. Zerenturk EJ, Kristiana I, Gill S, Brown AJ. 2012. The endogenous regulator 24(S),25-epoxycholesterol inhibits cholesterol synthesis at DHCR24 (Seladin-1). Biochim. Biophys. Acta 1821:1269-77
49. Briscoe J, Therond PP. 2013. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat. Rev. Mol. Cell Biol. 14:416-29
50. Corcoran RB, Scott MP. 2006. Oxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cells. PNAS 103:8408-13
51. Dwyer JR, Sever N, Carlson M, Nelson SF, Beachy PA, Parhami F. 2007. Oxysterols are novel activators of the hedgehog signaling pathway in pluripotent mesenchymal cells. J. Biol. Chem. 282:8959-68
52. Nachtergaele S, Mydock LK, Krishnan K, Rammohan J, Schlesinger PH, et al. 2012. Oxysterols are allosteric activators of the oncoprotein Smoothened. Nat. Chem. Biol. 8:211-20
53. Rohatgi R,Milenkovic L, ScottMP. 2007. Patched1 regulates Hedgehog signaling at the primary cilium. Science 317:372-76
54. Corbit KC, Aanstad P, Singla V, Norman AR, Stainier DY, Reiter JF. 2005. Vertebrate Smoothened functions at the primary cilium. Nature 437:1018-21
55. Nedelcu D, Liu J, Xu Y, Jao C, Salic A. 2013. Oxysterol binding to the extracellular domain of Smoothened in Hedgehog signaling. Nat. Chem. Biol. 9:557-64
56. Nachtergaele S, Whalen DM, Mydock LK, Zhao Z, Malinauskas T, et al. 2013. Structure and function of the Smoothened extracellular domain in vertebrate Hedgehog signaling. eLife 2:e01340
57. Myers BR, Sever N, Chong YC, Kim J, Belani JD, et al. 2013. Hedgehog pathwaymodulation bymultiple lipid binding sites on the smoothened effector of signal response. Dev. Cell 26:346-57
58. Wang C, Wu H, Katritch V, Han GW, Huang XP, et al. 2013. Structure of the human smoothened receptor bound to an antitumour agent. Nature 497:338-43
59. Chen JK, Taipale J, CooperMK, Beachy PA. 2002. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev. 16:2743-48
60. Umetani M, Shaul PW. 2011. 27-Hydroxycholesterol: The first identified endogenous SERM. Trends Endocrinol. Metab. 22:130-35
61. DuSell CD, Umetani M, Shaul PW, Mangelsdorf DJ, McDonnell DP. 2008. 27-Hydroxycholesterol is an endogenous selective estrogen receptor modulator. Mol. Endocrinol. 22:65-77
62. Wu Q, Ishikawa T, Sirianni R, Tang H, McDonald JG, et al. 2013. 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth. Cell Rep. 5:637-45
63. DuSell CD, Nelson ER, Wang X, Abdo J, Modder UI, et al. 2010. The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis. Endocrinology 151:3675-85
64. Nelson ER,DuSellCD,WangX,HoweMK,Evans G, et al. 2011. The oxysterol, 27-hydroxycholesterol, links cholesterol metabolism to bone homeostasis through its actions on the estrogen and liver X receptors. Endocrinology 152:4691-705
65. Umetani M, Domoto H, Gormley AK, Yuhanna IS, Cummins CL, et al. 2007. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat. Med. 13:1185-92
66. Umetani M, Ghosh P, Ishikawa T, Umetani J, Ahmed M, et al. 2014. The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha. Cell Metab. 20:172-82
67. Solt LA, Burris TP. 2012. Action of RORs and their ligands in (patho)physiology. Trends Endocrinol. Metab. 23:619-27
68. Wang Y, Kumar N, Solt LA, Richardson TI, Helvering LM, et al. 2010. Modulation of retinoic acid receptor-related orphan receptor and activity by 7-oxygenated sterol ligands. J. Biol. Chem. 285:5013-25
69. Wang Y, Kumar N, Crumbley C, Griffin PR, Burris TP. 2010. A second class of nuclear receptors for oxysterols: regulation of ROR and ROR activity by 24S-hydroxycholesterol (cerebrosterol). Biochim. Biophys. Acta 1801:917-23
70. Jin L, Martynowski D, Zheng S, Wada T, Xie W, Li Y. 2010. Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor ROR. Mol. Endocrinol. 24:923-29
71. Soroosh P,Wu J, Xue X, Song J, Sutton SW, et al. 2014. Oxysterols are agonist ligands of ROR t and drive Th17 cell differentiation. PNAS 111:12163-68
72. Rauen T, Juang YT, Hedrich CM, Kis-Toth K, Tsokos GC. 2012. A novel isoform of the orphan receptor ROR t suppresses IL-17 production in human T cells. Genes Immun. 13:346-50
73. Santori FR, Huang P, van de Pavert SA, Douglass EF Jr, Leaver DJ, et al. 2015. Identification of natural ROR ligands that regulate the development of lymphoid cells. Cell Metab. 21:286-97
74. Liu C, Yang XV, Wu J, Kuei C, Mani NS, et al. 2011. Oxysterols direct B-cell migration through EBI2. Nature 475:519-23
75. Raccosta L, Fontana R, Maggioni D, Lanterna C, Villablanca EJ, et al. 2013. The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils. J. Exp. Med. 210:1711-28
76. Paul SM, Doherty JJ, Robichaud AJ, Belfort GM, Chow BY, et al. 2013. The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors. J. Neurosci. 33:17290-300
77. Linsenbardt AJ, Taylor A, Emnett CM, Doherty JJ, Krishnan K, et al. 2014. Different oxysterols have opposing actions at N-methyl-D-aspartate receptors. Neuropharmacology 85:232-42
78. Kim WK, Meliton V, Amantea CM, Hahn TJ, Parhami F. 2007. 20(S)-Hydroxycholesterol inhibits PPAR expression and adipogenic differentiation of bone marrow stromal cells through a hedgehogdependent mechanism. J. Bone Miner. Res. 22:1711-19
79. Spann NJ, Glass CK. 2013. Sterols and oxysterols in immune cell function. Nat. Immunol. 14:893-900
80. Traversari C, Russo V. 2012. Control of the immune system by oxysterols and cancer development. Curr. Opin. Pharmacol. 12:729-35
81. Cyster JG, Dang EV, Reboldi A, Yi T. 2014. 25-Hydroxycholesterols in innate and adaptive immunity. Nat. Rev. Immunol. 14:731-43
82. McDonald JG, RussellDW. 2010. Editorial: 25-Hydroxycholesterol: A new life in immunology. J. Leukoc. Biol. 88:1071-72
83. Civra A, Cagno V, Donalisio M, Biasi F, Leonarduzzi G, et al. 2014. Inhibition of pathogenic nonenveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol. Sci. Rep. 4:7487
84. Bauman DR, Bitmansour AD, McDonald JG, Thompson BM, Liang G, Russell DW. 2009. 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production. PNAS 106:16764-69
85. Diczfalusy U, Olofsson KE, Carlsson AM, Gong M, Golenbock DT, et al. 2009. Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. J. Lipid Res. 50:2258-64
86. Park K, Scott AL. 2010. Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons. J. Leukoc. Biol. 88:1081-87
87. Gold ES, Diercks AH, Podolsky I, Podyminogin RL, Askovich PS, et al. 2014. 25-Hydroxycholesterol acts as an amplifier of inflammatory signaling. PNAS 111:10666-71
88. Reboldi A, Dang EV, McDonald JG, Liang G, Russell DW, Cyster JG. 2014. Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon. Science 345:679-84
89. Joseph SB, Bradley MN, Castrillo A, Bruhn KW, Mak PA, et al. 2004. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119:299-309
90. Korf H, Vander Beken S, Romano M, Steffensen KR, Stijlemans B, et al. 2009. Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice. J. Clin. Investig. 119:1626-37
91. A-Gonzalez N, Bensinger SJ, Hong C, Beceiro S, Bradley MN, et al. 2009. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31:245-58
92. Yi T, Wang X, Kelly LM, An J, Xu Y, et al. 2012. Oxysterol gradient generation by lymphoid stromal cells guides activated B cell movement during humoral responses. Immunity 37:535-48
93. Kelly LM, Pereira JP, Yi T, Xu Y, Cyster JG. 2011. EBI2 guides serial movements of activated B cells and ligand activity is detectable in lymphoid and nonlymphoid tissues. J. Immunol. 187:3026-32
94. Yi T, Cyster JG. 2013. EBI2-mediated bridging channel positioning supports splenic dendritic cell homeostasis and particulate antigen capture. eLife 2:e00757
95. Gatto D, Wood K, Caminschi I, Murphy-DurlandD, Schofield P, et al. 2013. The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells. Nat. Immunol. 14:446-53
96. Gatto D, Paus D, Basten A, Mackay CR, Brink R. 2009. Guidance of B cells by the orphan G proteincoupled receptor EBI2 shapes humoral immune responses. Immunity 31:259-69
97. Liu SY, Aliyari R, Chikere K, Li G, Marsden MD, et al. 2013. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity 38:92-105
98. BlancM,Hsieh WY, Robertson KA, Kropp KA, Forster T, et al. 2013. The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response. Immunity 38:106-18
99. AritaM, KojimaH,Nagano T,Okabe T, Wakita T, Shimizu H. 2013. Oxysterol-binding protein family I is the target of minor enviroxime-like compounds. J. Virol. 87:4252-60
100. Porter FD, Scherrer DE, Lanier MH, Langmade SJ, Molugu V, et al. 2010. Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci. Transl. Med. 2:56ra81
101. York AG, Bensinger SJ. 2013. Subverting sterols: rerouting an oxysterol-signaling pathway to promote tumor growth. J. Exp. Med. 210:1653-56
102. Zarrouk A, Vejux A, Mackrill J, O'Callaghan Y, Hammami M, et al. 2014. Involvement of oxysterols in age-related diseases and ageing processes. Ageing Res. Rev. 18:148-62
103. Bjorkhem I, Cedazo-Minguez A, Leoni V,Meaney S. 2009. Oxysterols and neurodegenerative diseases. Mol. Asp. Med. 30:171-79
104. Leoni V, Mariotti C, Tabrizi SJ, Valenza M, Wild EJ, et al. 2008. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease. Brain 131:2851-59
105. Leoni V,Mariotti C, Nanetti L, Salvatore E, Squitieri F, et al. 2011. Whole body cholesterolmetabolism is impaired in Huntington's disease. Neurosci. Lett. 494:245-49
106. Leoni V, Long JD, Mills JA, Di Donato S, Paulsen JS, PREDICT-HD Study Group. 2013. Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression. Neurobiol. Dis. 55:37-43
107. Lutjohann D, Papassotiropoulos A, Bjorkhem I, Locatelli S, Bagli M, et al. 2000. Plasma 24Shydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J. Lipid Res. 41:195-98
108. Mateos L, Ismail MA, Gil-Bea FJ, Leoni V, Winblad B, et al. 2011. Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer's disease. J. Alzheimer's Dis. 24:669-79
109. Teunissen CE, LutjohannD, von Bergmann K, Verhey F, Vreeling F, et al. 2003. Combination of serum markers related to several mechanisms in Alzheimer's disease. Neurobiol. Aging 24:893-902
110. Hughes TM, Kuller LH, Lopez OL, Becker JT, Evans RW, et al. 2012. Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease thanAlzheimer's disease. J. Alzheimer's Dis. 30:53-61
111. Solomon A, Leoni V, Kivipelto M, Besga A, Oksengard AR, et al. 2009. Plasma levels of 24Shydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. Neurosci. Lett. 462:89-93
112. Bretillon L, Siden A, Wahlund LO, Lutjohann D, Minthon L, et al. 2000. Plasma levels of 24Shydroxycholesterol in patients with neurological diseases. Neurosci. Lett. 293:87-90
113. Kolsch H, Heun R, Kerksiek A, Bergmann KV, MaierW, Lutjohann D. 2004. Altered levels of plasma 24S-and 27-hydroxycholesterol in demented patients. Neurosci. Lett. 368:303-8
114. Zuliani G, DonnorsoMP, Bosi C, Passaro A, Dalla Nora E, et al. 2011. Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: A case-control study. BMC Neurol. 11:121
115. Bjorkhem I, Andersson O, Diczfalusy U, Sevastik B, Xiu RJ, et al. 1994. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. PNAS 91:8592-96
116. Sharpe LJ, Burns V, Brown AJ. 2014. A lipidomic perspective on intermediates in cholesterol synthesis as indicators of disease status. J. Genet. Genomics 41:275-82
117. Griffiths WJ, Crick PJ,Wang Y. 2013. Methods for oxysterol analysis: past, present and future. Biochem. Pharmacol. 86:3-14
118. Schott HF, Lutjohann D. 2015. Validation of an isotope dilution gas chromatography-mass spectrometry method for combined analysis of oxysterols and oxyphytosterols in serum samples. Steroids 99:139-50
119. Brown AJ, Mander EL, Gelissen IC, Kritharides L,Dean RT, JessupW. 2000. Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells. Accumulation of oxidized esters in lysosomes. J. Lipid Res. 41:226-37
120. Farez MF, Quintana FJ, Gandhi R, Izquierdo G, Lucas M, Weiner HL. 2009. Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. Nat. Immunol. 10:958-64
121. Bjorkhem I, Diczfalusy U, Olsson T, Russell DW, McDonald JG, et al. 2011. Detecting oxysterols in the human circulation. Nat. Immunol. 12:577
122. Lund EG, Xie C, Kotti T, Turley SD, Dietschy JM, Russell DW. 2003. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J. Biol. Chem. 278:22980-88
123. Wong J, Quinn CM, Gelissen IC, Brown AJ. 2008. Endogenous 24(S),25-epoxycholesterol fine-tunes acute control of cellular cholesterol homeostasis. J. Biol. Chem. 283:700-7
124. Chen W, Chen G, Head DL, Mangelsdorf DJ, Russell DW. 2007. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell Metab. 5:73-79
125. Li-Hawkins J, Lund EG, Turley SD, Russell DW. 2000. Disruption of the oxysterol 7-hydroxylase gene in mice. J. Biol. Chem. 275:16536-42
126. Stiles AR, McDonald JG, Bauman DR, Russell DW. 2009. CYP7B1: one cytochrome P450, two human genetic diseases, and multiple physiological functions. J. Biol. Chem. 284:28485-89
127. Omoto Y, Lathe R,Warner M, Gustafsson JA. 2005. Early onset of puberty and early ovarian failure in CYP7B1 knockout mice. PNAS 102:2814-19
128. Chiang JYL, Kimmel R, Stroup D. 2001. Regulation of cholesterol 7-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXR). Gene 262:257-65
129. Meaney S, Hassan M, Sakinis A, Lutjohann D, von Bergmann K, et al. 2001. Evidence that the major oxysterols in human circulation originate from distinct pools of cholesterol: A stable isotope study. J. Lipid Res. 42:70-78
130. Lorbek G, Lewinska M, Rozman D. 2012. Cytochrome P450s in the synthesis of cholesterol and bile acids-from mouse models to human diseases. FEBS J. 279:1516-33
131. Metcalfe C, de Sauvage FJ. 2011. Hedgehog fights back: mechanisms of acquired resistance against Smoothened antagonists. Cancer Res. 71:5057-61
132. Lichtenstein AH, Brecher P. 1983. Esterification of cholesterol and 25-hydroxycholesterol by rat liver microsomes. Biochim. Biophys. Acta 751:340-48
133. Szedlacsek SE,Wasowicz E, Hulea SA, Nishida HI, Kummerow FA, Nishida T. 1995. Esterification of oxysterols by human plasma lecithin-cholesterol acyltransferase. J. Biol. Chem. 270:11812-19
134. Ren S, Hylemon P, Zhang ZP, Rodriguez-Agudo D, Marques D, et al. 2006. Identification of a novel sulfonated oxysterol, 5-cholesten-3,25-diol 3-sulfonate, in hepatocyte nuclei and mitochondria. J. Lipid Res. 47:1081-90
135. Ren S, Kim JK, Kakiyama G, Rodriguez-Agudo D, Pandak WM, et al. 2014. Identification of novel regulatory cholesterol metabolite, 5-cholesten, 3,25-diol, disulfate. PLOS ONE 9:e103621
136. Hughes TM, Lopez OL, Evans RW, Kamboh MI, Williamson JD, et al. 2014. Markers of cholesterol transport are associated with amyloid deposition in the brain. Neurobiol. Aging 35:802-7
137. LeoniV,Masterman T, Diczfalusy U, De Luca G, Hillert J, Bjorkhem I. 2002. Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis. Neurosci. Lett. 331:163-66
138. Teunissen CE, Dijkstra CD, Polman CH, Hoogervorst EL, von Bergmann K, Lutjohann D. 2003. Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients. Neurosci. Lett. 347:159-62
139. Lee CY, Seet RC, Huang SH, Long LH, Halliwell B. 2009. Different patterns of oxidized lipid products in plasma and urine of dengue fever, stroke, and Parkinson's disease patients: cautions in the use of biomarkers of oxidative stress. Antioxid. Redox Signal. 11:407-20
140. Karrenbauer VD, Leoni V, Lim ET, Giovannoni G, Ingle GT, et al. 2006. Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis. Clin. Neurol. Neurosurg. 108:456-60
141. van de Kraats C, Killestein J, Popescu V, Rijkers E, Vrenken H, et al. 2014. Oxysterols and cholesterol precursors correlate tomagnetic resonance imagingmeasures of neurodegeneration in multiple sclerosis. Mult. Scler. 20:412-17
142. Bjorkhem I, Lovgren-Sandblom A, Leoni V,Meaney S, Brodin L, et al. 2013. Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease. Neurosci. Lett. 555:102-5